CellaVision AB (publ) (STO:CEVI)
Sweden flag Sweden · Delayed Price · Currency is SEK
143.20
-2.80 (-1.92%)
Mar 24, 2026, 5:29 PM CET

CellaVision AB Revenue

In the year 2025, CellaVision AB had annual revenue of 758.97M SEK with 4.94% growth. CellaVision AB had revenue of 197.21M in the quarter ending December 31, 2025, with 5.63% growth.

Revenue
758.97M
Revenue Growth
+4.94%
P/S Ratio
4.56
Revenue / Employee
3.24M
Employees
231
Market Cap
3.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025758.97M35.75M4.94%
Dec 31, 2024723.22M45.93M6.78%
Dec 31, 2023677.29M37.95M5.94%
Dec 31, 2022639.34M73.79M13.05%
Dec 31, 2021565.55M94.11M19.96%
Dec 31, 2020471.44M9.67M2.09%
Dec 31, 2019461.77M96.96M26.58%
Dec 31, 2018364.81M55.50M17.94%
Dec 31, 2017309.31M44.27M16.70%
Dec 31, 2016265.04M25.65M10.71%
Dec 31, 2015239.39M22.47M10.36%
Dec 31, 2014216.92M37.07M20.61%
Dec 31, 2013179.85M10.34M6.10%
Dec 31, 2012169.51M14.11M9.08%
Dec 31, 2011155.40M23.76M18.05%
Dec 31, 2010131.64M22.66M20.80%
Dec 31, 2009108.97M8.53M8.49%
Dec 31, 2008100.44M25.88M34.71%
Dec 31, 200774.57M19.79M36.12%
Dec 31, 200654.78M15.76M40.39%
Dec 31, 200539.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Nolato AB9.46B
Vitrolife AB3.44B
MedCap AB2.11B
BICO Group AB1.50B
Xvivo Perfusion AB812.17M
C-Rad AB441.90M
Paxman AB323.56M
Bactiguard Holding AB225.57M
Revenue Rankings